|
Re: Resverlogix’ BETonMACE Phase 3 Trial Successfully Reaches its Targeted 250 MACE Events
|
4
|
Resverlogix Corp.
|
Apr 18, 2019 09:46AM
|
|
Re: Is there an average drop-out rate,..?
|
3
|
Resverlogix Corp.
|
Apr 18, 2019 09:36AM
|
|
Re: Resverlogix’ BETonMACE Phase 3 Trial Successfully Reaches its Targeted 250 MACE Events
|
6
|
Resverlogix Corp.
|
Apr 18, 2019 08:33AM
|
|
Resverlogix’ BETonMACE Phase 3 Trial Successfully Reaches its Targeted 250 MACE Events
|
4
|
Resverlogix Corp.
|
Apr 18, 2019 08:21AM
|
|
Re: Why is it taking so long Simple.
|
2
|
Resverlogix Corp.
|
Apr 17, 2019 05:40PM
|
|
Re: Why is it taking so long Simple.
|
4
|
Resverlogix Corp.
|
Apr 17, 2019 11:33AM
|
|
Re: SA blog post for those interested.....
|
6
|
Resverlogix Corp.
|
Apr 17, 2019 09:29AM
|
|
Re: Statistical Significance
|
3
|
Resverlogix Corp.
|
Apr 16, 2019 10:40PM
|
|
Re: Bromodomain and extraterminal domain (BET) inhibitors in clinical development
|
3
|
Resverlogix Corp.
|
Apr 16, 2019 09:42PM
|
|
Re: Bromodomain and extraterminal domain (BET) inhibitors in clinical development
|
3
|
Resverlogix Corp.
|
Apr 16, 2019 08:38PM
|
|
Rationale & Design paper and End of Dosing Announcement
|
5
|
Resverlogix Corp.
|
Apr 16, 2019 11:10AM
|
|
A couple recent epigenetic/bromodoma... reviews from 2018
|
3
|
Resverlogix Corp.
|
Apr 16, 2019 11:00AM
|
|
Re: Low Impact Journals
|
4
|
Resverlogix Corp.
|
Apr 15, 2019 04:34PM
|
|
Re: Scenario Analysis on end of BETonMACE Phase 3
|
4
|
Resverlogix Corp.
|
Apr 15, 2019 04:09PM
|
|
Re: MOA of Apabetalone - only affects sick patients
|
2
|
Resverlogix Corp.
|
Apr 15, 2019 09:58AM
|
|
Re: MOA of Apabetalone - only affects sick patients
|
5
|
Resverlogix Corp.
|
Apr 15, 2019 08:31AM
|
|
Re: Upcoming CVOT results
|
6
|
Resverlogix Corp.
|
Apr 15, 2019 08:14AM
|
|
Re: Upcoming CVOT results
|
4
|
Resverlogix Corp.
|
Apr 14, 2019 10:11PM
|
|
Re: Newbie
|
7
|
Resverlogix Corp.
|
Apr 14, 2019 09:02PM
|
|
Re: ERA-EDTA 2019 Symposium: Vascular calcification in kidney disease: Epigenetics as a novel approach?
|
4
|
Resverlogix Corp.
|
Apr 14, 2019 06:17PM
|
